|* Funding is as reported by grantees in the Annual Administrative Report and may not reflect actual Care Act funding.|
** CARE Act funding includes Ryan White CARE Act Title I, Title II base, Title II ADAP earmark, and other Ryan White CARE Act funding. Other funding includes Medicaid, Medicare, Federal Section 329, 330, 340, other Federal, State and Local funding, other public payments, manufacturer rebates, private contributions, and client payments.
Maine and Wyoming did not report an ADAP Annual Administrative Report for calendar year 2001. Georgia, North Carolina, and Guam did not report drug data in 2001.